Home › BAXTER HEALTHCARE CORPORATION › SEPRAFILM
SEPRAFILM
BAXTER HEALTHCARE CORPORATION · Model 508602 · UDI-DI 05413765589652
MCN
Prescription
0
510(k) clearances
1,558
Adverse events (30 deaths)
3
Recalls
20
Facilities
Description
Seprafilm Adhesion Barrier (membrane) is a sterile, bioresorbable, translucent adhesion barrier composed of two anionic polysaccharides, sodium hyaluronate (HA) and carboxymethylcellulose (CMC).
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2024-03-15 | Baxter Healthcare Corporation | Product was distributed in the United States without proper regulatory approval. |
| 2012-06-13 | Genzyme Corporation | Sterility of product may be compromised due to packaging defect |
| 2012-06-13 | Genzyme Corporation | Sterility of product may be compromised due to packaging defect |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.